Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
To study the individual effects of glucagon and growth hormone on human carbohydrate and lipid metabolism, endogenous secretion of both hormones was simultaneously suppressed with somatostatin and physiologic circulating levels of one or the other hormone were reproduced by exogenous infusion. The interaction of these hormones with insulin was evaluated by performing these studies in juvenile-onset, insulin-deficient diabetic subjects both during infusion of insulin and after its withdrawal. Infusion of glucagon (1 ng/kg-min) during suppression of its endogenous secretion with somatostatin produced circulating hormone levels of approximately 200 pg/ml. When glucagon was infused along with insulin, plasma glucose levels rose from 94 +/- 8 to 126 +/- 12 mg/100 ml over 1 h (P less than 0.01); growth hormone, beta-hydroxy-butyrate, alanine, FFA, and glycerol levels did not change. When insulin was withdrawn, plasma glucose, beta-hydroxybutyrate, FFA, and glycerol all rose to higher levels (P less than 0.01) than those observed under similar conditions when somatostatin alone had been infused to suppress glucagon secretion. Thus, under appropriate conditions, physiologic levels of glucagon can stimulate lipolysis and cause hyperketonemia and hyperglycemia in man; insulin antagonizes the lipolytic and ketogenic effects of glucagon more effectively than the hyperglycemic effect. Infusion of growth hormone (1 mug/kg-h) during suppression of its endogenous secretion with somastostatin produced circulating hormone levels of approximately 6 ng/ml. When growth hormone was administered along with insulin, no effects were observed. After insulin was withdrawn, plasma beta-hydroxybutyrate, glycerol, and FFA all rose to higher levels (P less than 0.01) than those observed during infusion of somatostatin alone when growth hormone secretion was suppressed; no difference in plasma glucose, alanine, and glucagon levels was evident. Thus, under appropriate conditions, physiologic levels of growth hormone can augment lipolysis and ketonemia in man, but these actions are ordinarily not apparent in the presence of physiologic levels of insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucagon has also effects on lipid metabolism stimulates lipolysis and hepatic fatty acid oxidation [197] but its effects should be always be considered relative to the insulin levels since insulin exerts opposite effects on lipid metabolism [198].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [198]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Felig, P. (1973) · Metabolism · doi:10.1016/0026-0495(73)90269-2 · Cited by 794
The essential role of glucagon in the pathogenesis of diabetes mellitus
Unger, R., & Orci, L. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92375-2 · Cited by 599
INHIBITION OF INSULIN SECRETION BY SOMATOSTATIN
Alberti, K. G. M. M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., & Ørskov, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92873-0 · Cited by 457
EFFECT OF GROWTH HORMONE ON PLASMA FATTY ACIDS*
Raben, M. S., & Hollenberg, C. H. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103824 · Cited by 445
Gerich, J. E., Lorenzi, M., Bier, D. M., Schneider, V., Tsalikian, E., Karam, J. H., & Forsham, P. H. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505082921901 · Cited by 354
Self-citationGlucagon levels and metabolic effects in fasting man
Marliss, E. B., Aoki, T. T., Unger, R. H., Soeldner, J. S., & Cahill, G. F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106445 · Cited by 339
Fain, J. N., Kovacev, V. P., & Scow, R. O. (1965) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)97175-9 · Cited by 270
Mortimer, C. H., Carr, D., Lind, T., Bloom, S. R., Mallinson, C. N., Schally, A. V., Tunbridge, W. M. G., Yeomans, L., Coy, D. H., Kastin, A., et al. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92903-1 · Cited by 268
Gerich, J. E., Lorenzi, M., Schneider, V., Karam, J. H., Rivier, J., Guillemin, R., & Forsham, P. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197409122911102 · Cited by 239
Self-citationGlucagon: Role in the Hyperglycemia of Diabetes Mellitus
Dobbs, R., Sakurai, H., Sasaki, H., Faloona, G., Valverde, I., Baetens, D., Orci, L., & Unger, R. (1975) · Science · doi:10.1126/science.1089999 · Cited by 229
Research works printed but not linked: 2
- [51]51. Lefebvre, P. 1972. Glucagon and lipid metabolism. In Glucagon: Molecular Physiology, Clinical and Therapeutic Implications. P. Lefebvre and R. H. Unger, editors. Pergamon Press, Inc., Elmsford, N. Y. 109–121.
- [57]57. Davidoff, F. 1968. The disturbances of carbohydrate metabolism in acromegaly—a perspective view, 19271967. Proc. Rudolf Virchow Med. Soc. City N. Y. 26 (Suppl.): 83-115.
Cited by
Items 101–199 of 199
Clemmons, D. R., Miller, S. S., & Mamputu, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179538 · Cited by 21
Some Hormonal Influences on Glucose and Ketone Body Metabolism in Normal Human Subjects
Johnston, D. G., Pernet, A., McCulloch, A., BLESA‐MALPICA, G., Burrin, J. M., & Alberti, K. G. M. M. (1982) · Novartis Foundation symposium · doi:10.1002/9780470720691.ch10 · Cited by 25
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Kitabchi, A. E., Umpierrez, G. E., & Murphy, M. B. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0708 · Cited by 22
Metabolomics Profiling of Patients With A−β+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis
Jahoor, F., Hsu, J. W.-C., Mehta, P. B., Keene, K. R., Gaba, R., Mulukutla, S. N., CADUCOY, E. I., Peacock, W. F., Patel, S. G., Bennet, R., et al. (2021) · Diabetes · doi:10.2337/db21-0066 · Cited by 23
Glucagon and Adipose Tissue Lipolysis
Lefèbvre, P. J. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68866-9_19 · Cited by 21
Crowne, E. C., Samra, J. S., Cheetham, T. D., Watts, A., Holly, J. M. P., & Dunger, D. B. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90189-5 · Cited by 22
Somatostatin and insulin secretion
Efendić, S., Lins, P., & Luft, R. (1978) · Metabolism · doi:10.1016/0026-0495(78)90058-6 · Cited by 20
(1977) · doi:10.1001/archinte.1977.03630170067016 · Cited by 19
Self-citationSomatostatin modulation of glucagon secretion and its importance in human glucose homeostasis
Gerich, J. E. (1978) · Metabolism · doi:10.1016/0026-0495(78)90059-8 · Cited by 22
Self-citationBratusch-Marrain, P. R., Waldh�usl, W. K., Grubeck‐Loebenstein, B., Korn, A., Vierhapper, H., & Nowotny, P. (1981) · Diabetologia · doi:10.1007/bf00252687 · Cited by 19
“individual counter-regulatory hormones [2, 43].”
BackgroundEbert, R., Arnold, R., & Creutzfeldt, W. (1977) · Gut · doi:10.1136/gut.18.2.121 · Cited by 18
Effect of glucagon on hepatic fatty acid oxidation and ketogenesis in conscious dogs.
Keller, U. B., & Shulman, G. I. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.2.e121 · Cited by 18
Metabolic interactions of glucagon and cortisol in man—Studies with somatostatin
Gill, A., Johnston, D. G., Ørskov, H., Batstone, G. F., & Alberti, K. G. M. M. (1982) · Metabolism · doi:10.1016/0026-0495(82)90104-4 · Cited by 18
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_21-2 · Cited by 17
Bharmal, S. H., Pendharkar, S. A., Singh, R. G., Cameron‐Smith, D., & Petrov, M. S. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1534242 · Cited by 18
Kullberg, J., Sundbom, M., Haenni, A., Fredén, S., Johansson, L., Börnert, P., Ahlström, A., Ahlström, H. K., & Karlsson, A. (2010) · Journal of Obesity · doi:10.1155/2011/959601 · Cited by 16
6 Hypoglycaemic Agents Which Do Not Release Insulin
Steiner, K., & Lien, E. L. (1987) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70423-5 · Cited by 17
Bianda, T., Hussain, M. A., Keller, A., Glatz, Y., Schmitz, O., Christiansen, J. S., Alberti, K. G. M. M., & Froesch, E. R. (1996) · Diabetologia · doi:10.1007/bf00403916 · Cited by 18
“GH has been shown to be ketogenic in insulin-deficient states (normal adults treated with somatostatin or diabetic patients) 9 If sufficient insulin is available, however, much of the ketogenic activity of GH is suppressed [42].”
BackgroundRegulation of Carbohydrate Metabolism by Cyclic Nucleotides
Exton, J. H. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68393-0_1 · Cited by 17
Disorders of Growth Hormone/Insulin-like Growth Factor Secretion and Action
Rosenfeld, R. G., & Cohen, P. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50013-2 · Cited by 26
Mauro, M. D., Papalia, G., Moli, R. L., Nativo, B., Nicoletti, F., & Lunetta, M. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00203-5 · Cited by 15
Fasting Decreases Rates of Noninsulin-Mediated Glucose Uptake in Man*
Baron, A., Brechtel, G., Wallace, P., & Edelman, S. V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-532 · Cited by 15
Physiological Role of Growth Hormone in Adult Life
Salomon, F., & Sönksen, P. H. (1987) · Acta Paediatrica · doi:10.1111/j.1651-2227.1987.tb17153.x · Cited by 15
Metabolic Status and Growth Hormone Secretion in Man
Vance, M. L. (1993) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1993.6.3-4.267 · Cited by 16
Selective suppression of hepatic glucose output by human proinsulin in the dog
Lavelle-Jones, M., Scott, M. H., Kolterman, O., Rubenstein, A. H., Olefsky, J. M., & Moossa, A. R. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.2.e230 · Cited by 14
Scheen, A. J., Krzentowski, G., Castillo, M. J., Lef�bvre, P. J., & LUYCKX, A. S. (1983) · Diabetologia · doi:10.1007/bf00251816 · Cited by 13
Endocrine Mediators of Metabolism Associated with Injury and Sepsis
Dahn, M. S., Jacobs, L. A., Lange, M. P., Smith, S. W., & Mitchell, R. A. (1986) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607186010003253 · Cited by 13
Chang, W., Zheng, A., Chen, Z. M., Zhang, S., Cai, H., & Liu, G. (2018) · animal · doi:10.1017/s1751731118002197 · Cited by 12
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_21 · Cited by 12
Whitelaw, D. C., & Gilbey, S. G. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500501 · Cited by 18
Acute Metabolic Complications of Diabetes
Newland‐Jones, P., Patel, M. A., & Dhatariya, K. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch41 · Cited by 11
In vitro glycation of brain aminophospholipids by acetoacetate and its inhibition by urea
Aguilar-Hernández, M., & Méndez, J. D. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.06.004 · Cited by 11
Identification of glucagon receptors in human adipocytes from a liposarcoma
Carranza, M. C., Simón, M. A., Torres, A., Romero, B., & Calle, C. (1993) · Journal of Endocrinological Investigation · doi:10.1007/bf03348878 · Cited by 11
ROLE OF GLUCAGON IN HUMAN DIABETIC KETOACIDOSIS: STUDIES USING SOMATOSTATIN
Gerich, J. E., Schneider, V. S., Lorenzi, M., Tsalikian, E., Karam, J. H., Bier, D. M., & Forsham, P. H. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb03838.x · Cited by 11
Self-citationBobo, R. C. (1977) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1977.02120220028003 · Cited by 10
Betley, S., Alberti, K. G. M. M., & Agius, L. (1989) · Biochemical Journal · doi:10.1042/bj2580547 · Cited by 10
Rizza, R. A., & Gerich, J. E. (1978) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31769-2 · Cited by 10
Self-citationMüller, W., Aoki, T. T., Egdahl, R. H., & Cahill, G. F. (1977) · Diabetologia · doi:10.1007/bf00996328 · Cited by 11
“[7] an infusion of physiologic amounts of glucagon in humans had lipolytic activity when infused together with somatostatin.”
BackgroundScheen, A. J., Gillet, J., Rosenthaler, J., Guiot, J., Henrivaux, P., Jandrain, B. J., & Lef�bvre, P. J. (1989) · Diabetologia · doi:10.1007/bf00264911 · Cited by 10
“This view is in agreement with the current role of glucagon [37] and GH [38] in ketogenesis, particularly in a state of insulin deprivation [33] as observed 3-6 h after interruption of the CSII.”
BackgroundResultProlonged Suppression of Insulin Release by a Somatostatin Analog
Lien, E. L., & Garsky, V. M. (1978) · Endocrinology · doi:10.1210/endo-103-1-81 · Cited by 10
Lefèbvre, P. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_7 · Cited by 12
Hormonal responses associated with early hyperglycemia after graded hemorrhage in dogs
McLeod, M. K., Carlson, D. E., & Gann, D. S. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.5.e597 · Cited by 9
Pharmacologic Compounds Affecting Glucagon Secretion
LUYCKX, A. S. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_10 · Cited by 9
Nosari, I., Lepore, G., Querci, F., Maglio, M. L., Sileo, F. G., & Pagani, G. A. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03350715 · Cited by 8
Rümelin, A., Nietgen, G. W., Pirlich, M., Thum, P., Bischoff, S. C., Schäfers, H., Mühlen, A. V. Z., & Kirchner, E. (1999) · Current Medical Research and Opinion · doi:10.1185/03007999909116506 · Cited by 8
On the Causes and Consequences of Abnormal Glucagon Secretion in Human Diabetes Mellitus
Gerich, J. E. (1977) · Springer eBooks · doi:10.1007/978-1-4612-6366-1_40 · Cited by 9
Self-citationTsakiridis, E. E., & Steinberg, G. R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70624 · Cited by 10
Growth Hormone, Prolactin, and Placental Lactogen in the Fetus and Newborn
Gurtünca, N., & Sperling, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00144-x · Cited by 9
da Rocha, A. F., Junior, P. S. P., Calefi, G. S., Marquezine, G. F., Morimoto, H. K., Mazzuco, T. L., de Faria, E. C., Urbano, M. R., & Carrilho, A. J. F. (2021) · Endocrine · doi:10.1007/s12020-021-02730-0 · Cited by 8
“Considering that humans spend most of their time in the postprandial state, we chose to study this phenomenon after a standard meal, where GH secretion and peripheral lipolysis were flattened and insulin increased [4, 15].”
BackgroundResultHolst, J. J. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_27 · Cited by 7
Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man
Schade, D. S., EATON, P. R., Pommer, I., & Temple, R. (1977) · Acta Diabetologica · doi:10.1007/bf02624664 · Cited by 7
Glucagon, gastric inhibitory polypeptide and the gastrocolic response
Strom, J. A., Condon, R. E., SCHULTE, W. J., Cowles, V. E., & Go, V. L. W. (1982) · The American Journal of Surgery · doi:10.1016/0002-9610(82)90147-7 · Cited by 7
Growth Hormone Hyperproduction Inducing some of the Vicious Circles in Diabetes Mellitus
Ørskov, H. (1985) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1985.tb02707.x · Cited by 7
Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery
Rosen, G., Marcove, R. C., Caparros, B., Nirenberg, A., Kosloff, C., & Huvos, A. G. (1979) · Cancer · doi:10.1002/1097-0142(197906)43:6<2306::aid-cncr2820430621>3.0.co;2-k · Cited by 585
Unger, R. H. (1978) · Disease-a-Month · doi:10.1016/s0011-5029(78)80006-6 · Cited by 6
Prevention of Diabetic Ketoacidosis
Schade, D. S. (1979) · JAMA · doi:10.1001/jama.1979.03300220061032 · Cited by 6
The ketotic effects of glucocorticoid and growth hormone in man
Schade, D. S., Eaton, R. P., & Peake, G. T. (1980) · Acta Diabetologica · doi:10.1007/bf02580998 · Cited by 5
Regulation of acid production in ketoacidosis and lactic acidosis
Hood, V. L., & Tannen, R. L. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050406 · Cited by 5
Recent Advances in Body Fuel Metabolism
Felig, P., & Koivisto, V. A. (1979) · Springer eBooks · doi:10.1007/978-1-4684-3447-7_9 · Cited by 6
Lack of influence of glucagon on glucose homeostasis after prolonged exercise in rats
Galbo, H., Richter, E. A., Holst, J. J., & Christensen, N. J. (1977) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00580805 · Cited by 5
“Furthermore, since the hyperglycemic effect of glucagon is highly dependent upon insulinopenia [12, 17, 18] the somewhat larger insulin concentrations after than during exercise (Fig.”
BackgroundDehydration-induced AVP stimulates glucagon release and ketogenesis
Hill, T. G., Briant, L. J. B., Kim, A., Wu, Y., Rorsman, P., Asterholm, I. W., & Benrick, A. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2024 · Cited by 5
Lenti, G., Trovati, M., Lorenzati, R., Vitelli, F., Tagliaferro, V., Marocco, A., & Pagano, G. (1980) · Acta Diabetologica · doi:10.1007/bf02582072 · Cited by 4
Cooperberg, B. A., & Cryer, P. (2010) · Diabetes · doi:10.2337/db10-0750 · Cited by 4
Glucagon and Lipoprotein Metabolism
Tiengo, A., & Nosadini, R. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68866-9_20 · Cited by 4
The Pharmacology and Potential Clinical Applications of Somatostatin and its Analogues
Gerich, J. E. (1980) · Springer eBooks · doi:10.1007/978-94-011-7712-2_2 · Cited by 4
Self-citationSgambato, S., Passariello, N., Giugliano, D., Torella, R., & D’Onofrio, F. (1981) · Acta Diabetologica · doi:10.1007/bf02047895 · Cited by 4
Somatomedin Hypothesis: Time for Reexamination
Kaplan, S. A. (2001) · The Endocrinologist · doi:10.1097/00019616-200111000-00008 · Cited by 4
Bier, D. M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050801 · Cited by 3
Self-citationThe Ketogenic Diet Alters Endocrine Regulation of Energy Metabolism in Ultra‐Endurance Athletes
Miller, V. J., Hyde, P. N., Dickerson, R. M., LaFountain, R. A., Maresh, C. M., Kraemer, W. J., & Volek, J. S. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.1036.3 · Cited by 3
Effects of Prolactin and Growth Hormone on Tissue and Serum Carnitine in the Rat*
GOODMAN, A. D., Hoekstra, S., Busch, R. S., Meyer, G. S., & Abend, S. (1988) · Endocrinology · doi:10.1210/endo-123-4-1955 · Cited by 3
7 Metabolic effects of gut hormones
Hayes, J. R., & Henry, R. (1979) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(79)80046-8 · Cited by 3
GROWTH HORMONE, BIOCHEMICAL ASPECTS
Trygstad, O. (1978) · Elsevier eBooks · doi:10.1016/b978-0-08-022629-3.50015-5 · Cited by 3
Contrainsulin Hormones: Biochemical and Physiological Aspects
Gerich, J. E., & Cryer, P. E. (1991) · Springer eBooks · doi:10.1007/978-1-4684-0400-5_6 · Cited by 3
Self-citationPERIOPERATIVE PROBLEMS IN THE DIABETIC
Larkins, R. G. (1978) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1978.tb05222.x · Cited by 2
Fatty Acid Metabolism in Diabetes
Bhathena, S. J. (2007) · Food science and technology · doi:10.1201/9781420006902.ch47 · Cited by 2
Pleotropic Acute and Chronic Effects of Leptin to Reverse Type 1 Diabetes
Perry, R. J. (2017) · Postdoc Journal · doi:10.14304/surya.jpr.v5n1.2 · Cited by 2
“To that end, Roger Unger and colleagues hypothesized that suppression of hyperglucagonemia, which has been demonstrated in animals (32, 44, 47-51) and humans (52-56) with insulinopenic diabetes, may explain leptin’s chronic ability to correct”
BackgroundHiperglucemia inducida por glucocorticoides en el paciente hospitalizado: enfoque y manejo
Lopera, R. T., Barrera, A. F. C., & Rojas, W. (2019) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.6.1.469 · Cited by 3
Björkman, O., Felig, P., & Wahren, J. (1984) · Clinical Physiology · doi:10.1111/j.1475-097x.1984.tb00117.x · Cited by 2
Kheirollah, A., Maghuli, A., Dalvand, P., Mohaghegh, M., Barat, T., & Aberomand, M. (2015) · Jentashapir Journal of Health Research · doi:10.17795/jjhr-25864 · Cited by 1
“Dehydration in ketoacidotic and nonketoacidotic hyperglycemia is accompanied by elevation in counter regulatory hormones such as catecholamines, cortisol, and growth hormone, which increase serum glucose level (11-13).”
BackgroundHaase, M., Kahle, M., Janert, M., Meier, J. J., & Nauck, M. A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12868 · Cited by 1
Pasquel, F. J., & Umpierrez, G. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00046-9 · Cited by 1
Daughaday, W. H. (1978) · Springer eBooks · doi:10.1007/978-1-4684-2502-4_2 · Cited by 1
Wechselbeziehungen zwischen Triglyceriden, Fettsäure- und Glucose-Metaboliten
Schmülling, R. M., Geiseler, D., & Eggstein, M. (1978) · Zusammenarbeit von Klinik und klinischer Chemie · doi:10.1007/978-3-642-81227-9_16 · Cited by 1
Gerich, J. E. (1977) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-8849-8_15 · Cited by 1
Self-citationSerum ketone response to glucagon as a marker of insulin dependency in diabetics
Watanabe, T., Sugiyama, H., UCHIMURA, I., & MAEZAWA, H. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90116-u · Cited by 1
Effects of glucagon on liver metabolism in intact dogs
Schütz, W., Raberger, G., Kraupp, O., & Brugger, G. (1977) · Research in Experimental Medicine · doi:10.1007/bf01851358 · Cited by 1
Creating Growth Hormone Resistance in Cells using a Hammerhead Ribozyme Approach
List, E. O. (2001) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
New Concepts in Glucagon Physiology
Sherwin, R. S., & Felig, P. (1977) · Springer eBooks · doi:10.1007/978-1-4612-6366-1_38 · Cited by 1
Glucagon and Hypertriglyceridemia
Tiengo, A., Nosadini, R., Garotti, M. C., Fedele, D., Muggeo, M., & Crepaldi, G. (1977) · Springer eBooks · doi:10.1007/978-1-4612-6366-1_49 · Cited by 1
Felig, P., & Koivisto, V. A. (1978) · Springer eBooks · doi:10.1007/978-1-4684-2499-7_4 · Cited by 1
Diagnostic and Therapeutic Applications of Gastrointestinal Hormones
Misra, P. S., & Baruh, S. (1983) · Springer eBooks · doi:10.1007/978-94-009-6601-7_3
Molitch, M. E. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2584-1_4 · Cited by 1
Turner, J. M. (2005) · UWA Profiles and Research Repository (UWA)
Zhou, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i25.3925
Hormonal Response to Prolonged Endurance Exercise in Elite Keto-Adapted Ultra-Endurance Athletes
Hyde, P. N. (2017) · The Knowledge Bank (The Ohio State University)
Social stress, obesity and glucose tolerance: a psychobiological investigation
Sanghez, V. (2012) · DSpaceUnipr (University of Parma)
Unger, R. H. (1978) · Springer eBooks · doi:10.1007/978-1-4684-2499-7_3
Franz, I.-W. (1986) · Springer eBooks · doi:10.1007/978-3-642-71340-8_6
Metadata
- Authors
- Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1976-04-01
- Volume
- 57
- Issue
- 4
- Pages
- 875-884
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC436731
- OpenAlex
- W2003781513
- Cited by
- 198
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 2 · 2012: 1
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glucagon, growth hormone, insulin, somatostatin, carbohydrate metabolism, lipid metabolism, lipolysis, ketogenesis, hyperketonemia, hyperglycemia, insulin deficiency, type 1 diabetes, beta-hydroxybutyrate, free fatty acids, glycerol, alanine, insulin antagonism
- MeSH terms
- Adult, Alanine, Blood Glucose, Depression, Chemical, Diabetes Mellitus, Fatty Acids, Nonesterified, Female, Glucagon, Glycerol, Humans, Hydroxybutyrates, Male, Somatostatin, Growth Hormone, Diabetic Ketoacidosis, Carbohydrate Metabolism, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.